DG Capital Management (Massachusetts)’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-12,935	Closed	-$82K	–	67
2014 Q2	$82K	Buy	+12,935	New	+$82K	0.05%	62